Clinical trial Recruiting at 1 site Observational

Registry for patients with deep venous obstructions

Official title: Ongoing Registry of Deep Venous Reconstructions

Run by Maastricht University Medical Center · NCT02650453 · Data updated 2026-11-12

This study collects information from patients with deep vein blockages who are getting treated with a specific procedure to see how well it works and if it's safe.

Quick facts

Study typeObservational
SexAll
Enrollment1000 (estimated)
SponsorMaastricht University Medical Center
Academic / other
Locations1 site (Maastricht)
StatusRecruiting
StartedSeptember 2009
Main results expectedSeptember 2019
Study endsSeptember 2029
Registry record updatedJanuary 8, 2016
Trial IDNCT02650453 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients with venous obstruction in the femoral vein or iliac veins who experience significant symptoms.

Probably not a fit

Patients who are intolerant to anticoagulant medication or have a life expectancy of less than one year may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This ongoing registry collects data on patients suffering from deep venous obstructive disease who are treated using percutaneous transluminal angioplasty (PTA) and stenting, with or without surgical desobstruction of the common femoral vein. The study aims to document the effectiveness and safety of these interventions in patients with significant symptoms and confirmed venous obstruction through imaging techniques. The data is continuously updated in a digital database at a tertiary medical center, allowing for real-time analysis and insights into treatment outcomes.

Why it matters

Potential benefit: If successful, this registry could improve treatment strategies and outcomes for patients with deep venous thrombosis.

How similar studies have gone: Previous studies have shown that endovenous reconstructions are safe and effective, indicating a promising approach in this area.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Venous obstruction/occlusion in the femoral vein, common femoral vein, external iliac vein, common iliac vein or inferior vena cava

Exclusion Criteria:

* Intolerance to anticoagulant medication
* A life expectancy \<1 year

Where it's running

  • Maastricht University Medical Centre
    Maastricht, Netherlands
    Recruiting

Study contacts

  • Principal investigator: Cees Wittens, MD, PhD — Maastricht University Medical Centre
  • Study coordinator: Mark A de Wolf, MD
  • Email: m.dewolf@maastrichtuniversity.nl

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.